Income statement
USD
Annual
| Metric | 2021 | 2020 | 2019 | 2018 | 2012 |
|---|---|---|---|---|---|
| Revenue | 162K | 2K | 0 | 0 | 0 |
| Gross Profit | 21K | 2K | 0 | 0 | -2K |
| Operating Income | -59K | -197K | -95K | -51K | -583K |
| EBITDA | 197K | 146K | -95K | -51K | -582K |
| Net Income | -35K | -78K | -102K | -60K | -586K |
| EPS (Diluted) | — | — | — | — | — |
Consumer Defensive
Live Price
Offline$6.37
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 2, 2026
Coverage: 237 bars · Jun 23, 2025 → Jun 2, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Stevia Nutra Corp (STNT) is a Consumer Defensive stock with a market cap of $160.00M and listed on OTC. The stock last traded around $6.37 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 2, 2026). Baseline metrics include revenue growth of +7823.2%, EPS growth of +65.0%, a dividend yield of 0.0%. What stands out right now is revenue +7823.2%, EPS +65.0%, free cash flow +14.1% with operating margin -36.4% and ROIC -81.9%. Valuation already assumes a fairly strong business story at price/sales 1000.2. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines STNT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
STNT
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
STNT Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for STNT and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$586.5K
-876.7% YoY
Free Cash Flow
-$286.0K
-454.1% YoY
Revenue Growth
+7823.2%
EPS Growth
+65.0%
Gross Margin
13.2%
Net Margin
-21.8%
Income statement
USD
| Metric | 2021 | 2020 | 2019 | 2018 | 2012 |
|---|---|---|---|---|---|
| Revenue | 162K | 2K | 0 | 0 | 0 |
| Gross Profit | 21K | 2K | 0 | 0 | -2K |
| Operating Income | -59K | -197K | -95K | -51K | -583K |
| EBITDA | 197K | 146K | -95K | -51K | -582K |
| Net Income | -35K | -78K | -102K | -60K | -586K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2021 | 2020 | 2019 | 2018 | 2012 |
|---|---|---|---|---|---|
| Cash & Equivalents | 62K | 12K | 17K | 2K | 22K |
| Total Assets | 274K | 25K | 17K | 2K | 87K |
| Total Liabilities | 421K | 192K | 301K | 195K | 83K |
| Shareholder Equity | -134K | -167K | -284K | -192K | 4K |
| Total Debt | 219K | 86K | 165K | 58K | 20K |
| Net Debt | 157K | 75K | 148K | 56K | -2K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
252K
-388.8% YoY
Capital Expenditures
34K
Free Cash Flow
286K
-454.1% YoY
Key ratios
Gross Margin
13.2%
Operating Margin
-36.4%
Net Margin
-21.8%
ROE
23.5%
Debt / Equity
-1.63x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.